Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dynegy Inc
DYN | US
14.86
USD-0.34
-2.24%
DYN | US
About Dynegy Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
06/03/2026
Close
14.86
Open
14.75
High
15.36
Low
14.46
Dyne Therapeutics Inc. a muscle disease company operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1 duchenne muscular dystrophy and facioscapulohumeral dystrophy as well as rare skeletal muscle and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics Inc. was incorporated in 2017 and is headquartered in Waltham Massachusetts.
View LessDYN | US
Risk
59.0
Sharpe
0.19
Luna's Score
39/100
Recommendation
Sell
Luna says (DYN | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
66.1%1 month
59.0%3 months
66.9%6 months
90.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.56
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-8.87
Ent. to rev.
-
PEG
0.19
Other Fundamentals
EBITDA
-269.47M
MarketCap
1.49B
MarketCap(USD)
1.49B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-52.46
Short ratio
4.43
Short perc.
10.53
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.34
Range1M
5.11
Range3M
9.96
Volumes: Market Activity
Rel. volume
1.37
Price X volume
38.49M
